These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 652146)

  • 1. Serum dopamine-beta-hydroxylase in affective disorders.
    Strandman E; Wetterberg L; Perris C; Ross SB
    Neuropsychobiology; 1978; 4(4):248-55. PubMed ID: 652146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
    Meltzer HY; Cho HW; Carroll BJ; Russo P
    Arch Gen Psychiatry; 1976 May; 33(5):585-91. PubMed ID: 1267575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma dopamine beta hydroxylase activity in affective disorders.
    Levitt M; Dunner DL; Mendlewicz J; Frewin DB; Lawlor W; Fleiss JL; Stallone F; Fieve RR
    Psychopharmacologia; 1976 Mar; 46(2):205-10. PubMed ID: 951455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum dopamine-beta-hydroxylase in diagnostic subgroups of depressed patients and in relation to their personality characteristics.
    Eisemann M; Ericsson U; Von Knorring L; Perris C; Perris H; Ross S
    Neuropsychobiology; 1983; 9(4):193-6. PubMed ID: 6646390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.
    Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W
    Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression.
    Sapru MK; Rao BS; Channabasavanna SM
    Acta Psychiatr Scand; 1989 Nov; 80(5):474-8. PubMed ID: 2596346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic study of plasma dopamine beta-hydroxylase in affective disorder.
    Levitt M; Mendlewicz J
    Mod Probl Pharmacopsychiatry; 1975; 10():89-98. PubMed ID: 1177948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma dopamine-beta-hydroxylase in depressed patients.
    Matuzas W; Meltzer HY; Uhlenhuth EH; Glass RM; Tong C
    Biol Psychiatry; 1982 Dec; 17(12):1415-24. PubMed ID: 7159639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
    Hess C; Reif A; Strobel A; Boreatti-Hümmer A; Heine M; Lesch KP; Jacob CP
    J Neural Transm (Vienna); 2009 Feb; 116(2):121-30. PubMed ID: 18982239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression.
    Puzynski S; Rode A; Zaluska M
    Acta Psychiatr Scand; 1983 Feb; 67(2):89-95. PubMed ID: 6846042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
    Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
    Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-zero plasma dopamine-beta-hydroxylase and conduct disorder in emotionally disturbed boys.
    Rogeness GA; Hernandez JM; Macedo CA; Amrung SA; Hoppe SK
    J Am Acad Child Psychiatry; 1986 Jul; 25(4):521-7. PubMed ID: 3745733
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum dopamine-beta-hydroxylase activity: clinical applications in child psychiatry.
    Young JG; Kyprie RM; Ross NT; Cohen DJ
    J Autism Dev Disord; 1980 Mar; 10(1):1-14. PubMed ID: 6085951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dopamine-beta-hydroxylase activity in patients with major depressive disorders.
    Kjellman BF; Beck-Friis J; Ljunggren JG; Ross SB; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1986 Mar; 73(3):266-70. PubMed ID: 3716844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-beta-hydroxylase activity after acute myocardial infarction.
    Ogawa K; Yamazaki N; Suzuki Y; Sassa H
    Jpn Heart J; 1977 May; 18(3):348-56. PubMed ID: 881749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum dopamine-beta-hydroxylase activity in depression and anxiety.
    Friedman MJ; Stolk JM; Harris PQ; Cooper TB
    Biol Psychiatry; 1984 Apr; 19(4):557-70. PubMed ID: 6733175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum dopamine beta-hydroxylase activity. A marker of congestive heart failure.
    Horwitz LD; Travis VL
    J Clin Invest; 1978 Nov; 62(5):899-906. PubMed ID: 711856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.